-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TH-104 in Pruritus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TH-104 in Pruritus report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TH-104 in Pruritus Drug Details: Nalmefene (AV-104) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Elafibranor in Primary Biliary Cholangitis (Primary Biliary Cirrhosis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Elafibranor in Primary Biliary Cholangitis (Primary Biliary Cirrhosis) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Elafibranor in Primary Biliary Cholangitis (Primary Biliary Cirrhosis)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Difelikefalin in Notalgia Paresthetica
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Difelikefalin in Notalgia Paresthetica report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Difelikefalin in Notalgia Paresthetica Drug Details: Difelikefalin Acetate (Korsuva, Kapruvia) is a...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Foralumab in Secondary Progressive Multiple Sclerosis (SPMS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Foralumab in Secondary Progressive Multiple Sclerosis (SPMS) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Foralumab in Secondary Progressive Multiple Sclerosis (SPMS) Drug Details:...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Odevixibat in Biliary Atresia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Odevixibat in Biliary Atresia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Odevixibat in Biliary Atresia Drug Details: Odevixibat Sesquihydrate (Bylvay) is acts by...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ustekinumab in Pouchitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ustekinumab in Pouchitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ustekinumab in Pouchitis Drug Details: Ustekinumab (Stelara, Finlius) is a human monoclonal antibody...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Adrabetadex in Atherosclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Adrabetadex in Atherosclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adrabetadex in Atherosclerosis Drug Details: Adrabetadex is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IPN-60250 in Primary Biliary Cholangitis (Primary Biliary Cirrhosis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IPN-60250 in Primary Biliary Cholangitis (Primary Biliary Cirrhosis) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IPN-60250 in Primary Biliary Cholangitis (Primary Biliary Cirrhosis)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IPN-60250 in Liver Diseases
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IPN-60250 in Liver Diseases report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IPN-60250 in Liver Diseases Drug Details: A-3907 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Seladelpar Lysine in Primary Biliary Cholangitis (Primary Biliary Cirrhosis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Seladelpar Lysine in Primary Biliary Cholangitis (Primary Biliary Cirrhosis) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Seladelpar Lysine in Primary Biliary Cholangitis...